Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2005
12/06/2005CA2349338C Novel macrolide antibiotics
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/06/2005CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
12/06/2005CA2096528C Retroviral protease inhibitors
12/06/2005CA2073282C Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use
12/04/2005CA2568914A1 Therapeutic agents, and methods of making and using the same
12/01/2005WO2005113602A1 Coiled-coil microbial antigens
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113508A1 Stable crystal of 4-oxoquinoline compound
12/01/2005WO2005113014A1 siRNA TO VP-1 OF JC VIRUS AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/01/2005WO2005112648A1 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
12/01/2005WO2005095403A3 Macrocyclic compounds as inhibitors of viral replication
12/01/2005WO2005065015A3 Neutralizing antibodies and methods of use thereof
12/01/2005WO2005053650A8 Azithromycin dosage forms with reduced side effects
12/01/2005WO2005025487A3 Oligonucleotides targeting prion diseases
12/01/2005WO2005011730A8 Microsome vaccine
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005US20050267211 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050267156 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
12/01/2005US20050267153 Administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof, or immunomodulating/immunostimulating agents; inhibiting replication and secretion, reduced toxicity
12/01/2005US20050267136 Method of inhibiting dihydrofolate reductase; screening assay for the identification of novel therapeutics and their cellular targets
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267105 Bicyclic heterocycles as HIV integrase inhibitors
12/01/2005US20050267092 Novel cephalosporin compounds and process for preparing the same
12/01/2005US20050267079 Tetracycline derivatives and methods of use thereof
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267048 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
12/01/2005US20050267035 Peptide and polypeptide inhibitors of complement C1s
12/01/2005US20050267020 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
12/01/2005US20050267019 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents
12/01/2005US20050266549 Molecular switch for regulating mammalian gene expression
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266488 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266399 HCV regulated protein expression
12/01/2005US20050266050 Antimicrobial composition and method for use
12/01/2005US20050266025 Novel use
12/01/2005US20050266024 Adjuvant
12/01/2005US20050266020 Modular transport systems for molecular substances and production and use thereof
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005CA2767912A1 Synthesis of tetracyclines and analogues thereof
12/01/2005CA2567404A1 Cyclopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005CA2566755A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005CA2562915A1 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
11/2005
11/30/2005EP1600454A1 Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside
11/30/2005EP1600452A2 Synthesis of 2'-deoxy-L-nucleosides
11/30/2005EP1600451A2 Synthesis of 2'-deoxy-l-nucleosides
11/30/2005EP1600448A2 Enantiomerically pure beta-D-(-)-Dioxolane-Nucleosides
11/30/2005EP1600155A1 The use of polyols in combating yeast infection and polyol preparations for said use
11/30/2005EP1599581A2 Production of a live vaccine directed against influenza viruses
11/30/2005EP1599495A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
11/30/2005EP1599491A1 Bifunctional heterocyclic compounds and methods of making and using the same
11/30/2005EP1599471A1 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
11/30/2005EP1599470A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
11/30/2005EP1599440A2 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
11/30/2005EP1599217A2 Methods for inhibiting viral replication in vivo
11/30/2005EP1599194A1 Use of active ingredients for the prophylaxis and/or therapy of viral diseases
11/30/2005EP1599174A2 Novel compounds
11/30/2005EP1599172A2 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
11/30/2005EP1599164A2 Methods for treating, preventing and detecting helicobacter infection
11/30/2005EP1511385B1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
11/30/2005EP1406607B1 Verwendung einer antiviralen verbindungsklasse (dithiocarbamat-verbindungen) zur herstellung eines mittels zur behandlung bzw. pravention einer virusinfektion im respiratorischen trakt
11/30/2005EP1357123B1 Novel carbapenem, medical and antibacterial comprisisng the same, and uses thereof
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1301605B1 Nk cells activating receptors and their therapeutic and diagnostic uses
11/30/2005EP1287005B1 Benzoic acid esters having antiplasmid effect
11/30/2005EP1252179B1 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
11/30/2005EP1221941A4 Powder pharmaceutical formulations
11/30/2005EP1196586B1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis
11/30/2005EP1194436B1 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
11/30/2005EP1078063B1 Basb029 polynucleotides and polypeptides from neisseria meningitis
11/30/2005EP1071474B1 Substituted porphyrins
11/30/2005EP1056771B1 Streptogramin derivatives, preparation method and compositions containing same
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005EP0936922B1 Polynucleotide vaccine formula for treating horse diseases
11/30/2005EP0870828B1 Novel polypeptide originating from hemophilus paragallinarum and process for producing the same
11/30/2005EP0491793B1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents
11/30/2005CN1703513A Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
11/30/2005CN1703504A Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vivo$
11/30/2005CN1703425A Crystallization of IGF-1
11/30/2005CN1703246A Solution for ungual and peri-ungual application
11/30/2005CN1703238A Recombinant intracellular pathogen immunogenic compositions and methods for use
11/30/2005CN1703206A Plaster for the treatment of dysfunctions and disorders of nail growth
11/30/2005CN1701791A Medicine for treating allergic skin disease and its preparation process
11/30/2005CN1701788A Avian polynucleotide vaccine formula
11/30/2005CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
1 ... 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 ... 1798